新型冠状病毒肺炎疫苗有效性和安全性概述  

Efficacy and safety of COVID-19 vaccine

作　　者：杨惠洁 孙誉芳 王军志[1] 李长贵[1] YANG Hui-jie;SUN Yu-fang;WANG Jun-zhi;LI Chang-gui(National Institutes for Food and Drug Control,Beijing 102629,China;Guangzhou Medical University,Guangzhou 511436,China)

机构地区：[1]中国食品药品检定研究院,北京102629 [2]广州医科大学,广州511436

出　　处：《中国新药杂志》2022年第21期2082-2089,共8页Chinese Journal of New Drugs

摘　　要：新型冠状病毒肺炎疫苗的研发和使用在应对全球由新型冠状病毒感染引起的肺炎疾病中发挥着举足轻重的作用,已被世界卫生组织(WHO)授权在全球紧急使用的11种疫苗在临床试验和真实世界中均表现出对预防感染、重症和死亡的有效保护作用,并且整体安全性良好,是人类有效防控新型冠状病毒感染和传播的有力武器。本文就新型冠状病毒肺炎疫苗的有效性和安全性概况进行简要综述。The research, development and application of corona virus disease 2019(COVID-19) vaccine play an important role against the global pneumonia caused by severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) infection. There are 11 candidate vaccines that have been issued for emergency use list(EUL) by WHO, which have been shown effective protection with safety against infection, severe diseases and death in clinical trials and real world. They have become powerful weapons for human beings to prevent infection and transmission of SARS-CoV-2. In this paper, the efficacy and safety of COVID-19 vaccines were briefly reviewed.

关 键 词：新型冠状病毒肺炎疫苗 有效性 安全性 

分 类 号：R972.6[医药卫生—药品]